Article
Outcomes of A Pilot Newborn Screening Program for Spinal Muscular Atrophy in A Spanish Region
2024-12-03
Abstract excerpt
Spinal muscular atrophy (SMA) is a degenerative neuromuscular condition resulting from a homozygous deletion of survival motor neuron 1 (SMN1) gene in 95% of patients. A timely diagnosis via newborn screening (NBS) and initiating treatment before the onset of symptoms are critical for improving health outcomes in affected individuals. We carried out a screening test by quantitative PCR (qPCR) to amplify the exon s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8438026f-8ec1-5f32-9336-fe373e0f2455
- DOI
- 10.20944/preprints202412.0070.v1
